218 related articles for article (PubMed ID: 31937855)
1. Antihypertensive therapy and sudden cardiac death, should we expect the unexpected?
Sanidas E; Malliaras K; Papadopoulos D; Velliou M; Tsakalis K; Zerva K; Barbetseas J
J Hum Hypertens; 2020 May; 34(5):339-345. PubMed ID: 31937855
[TBL] [Abstract][Full Text] [Related]
2. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
[TBL] [Abstract][Full Text] [Related]
3. Hypertension, left ventricular hypertrophy, and sudden cardiac death.
Shenasa M; Shenasa H
Int J Cardiol; 2017 Jun; 237():60-63. PubMed ID: 28285801
[TBL] [Abstract][Full Text] [Related]
4. A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure.
Koracevic G; Perisic Z; Stanojkovic M; Stojanovic M; Zdravkovic M; Tomasevic M; Djordjevic D; Mladenovic K; Koracevic M; Trkulja J
Med Princ Pract; 2022; 31(5):454-462. PubMed ID: 36044874
[TBL] [Abstract][Full Text] [Related]
5. QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.
Morin DP; Oikarinen L; Viitasalo M; Toivonen L; Nieminen MS; Kjeldsen SE; Dahlöf B; John M; Devereux RB; Okin PM
Eur Heart J; 2009 Dec; 30(23):2908-14. PubMed ID: 19687165
[TBL] [Abstract][Full Text] [Related]
6. Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.
Koracevic G; Stojanovic M; Lovic D; Zdravkovic M; Sakac D
J Hum Hypertens; 2021 Jul; 35(7):564-576. PubMed ID: 33654234
[TBL] [Abstract][Full Text] [Related]
7. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death.
Messerli FH; Soria F
Am J Med; 1992 Aug; 93(2A):21S-26S. PubMed ID: 1387763
[TBL] [Abstract][Full Text] [Related]
8. Hypertension and sudden cardiac death.
Messerli FH
Am J Hypertens; 1999 Dec; 12(12 Pt 3):181S-188S. PubMed ID: 10619570
[TBL] [Abstract][Full Text] [Related]
9. [Sudden cardiac death in patients with arterial hypertension and left ventricular hypertrophy on antihypertensive therapy].
Lietava J; Dúbrava M
Bratisl Lek Listy; 1997; 98(7-8):390-5. PubMed ID: 9471332
[TBL] [Abstract][Full Text] [Related]
10. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis.
Bayés-Genís A; Guindo J; Viñolas X; Tomás L; Elosua R; Duran I; Bayés de Luna A
Am J Cardiol; 1995 Nov; 76(13):54D-59D. PubMed ID: 7495219
[TBL] [Abstract][Full Text] [Related]
11. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Krauser DG; Devereux RB
Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
[TBL] [Abstract][Full Text] [Related]
12. Hypertension: left ventricular hypertrophy, ventricular ectopy, and sudden death.
Ketelhut R; Messerli FH
Prim Care; 1991 Sep; 18(3):577-92. PubMed ID: 1835104
[TBL] [Abstract][Full Text] [Related]
13. Hypertensive heart disease--significance of left ventricular hypertrophy.
Schmieder RE
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
[TBL] [Abstract][Full Text] [Related]
14. Hypertension, myocardial ischemia, and sudden death.
Yamani MH; Massie BM
Curr Opin Cardiol; 1994 Sep; 9(5):542-50. PubMed ID: 7987033
[TBL] [Abstract][Full Text] [Related]
15. Hypertensive heart disease, ventricular dysrhythmias, and sudden death.
Messerli FH; Michalewicz L
Adv Exp Med Biol; 1997; 432():263-72. PubMed ID: 9433533
[No Abstract] [Full Text] [Related]
16. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.
Paoletti E; Specchia C; Di Maio G; Bellino D; Damasio B; Cassottana P; Cannella G
Nephrol Dial Transplant; 2004 Jul; 19(7):1829-34. PubMed ID: 15128888
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.
Okin PM; Kjeldsen SE; Julius S; Dahlöf B; Devereux RB
Heart Rhythm; 2012 Apr; 9(4):531-7. PubMed ID: 22079554
[TBL] [Abstract][Full Text] [Related]
18. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
Schmieder RE; Messerli FH
Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
[TBL] [Abstract][Full Text] [Related]
19. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
20. Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.
Messerli FH; Soria F
Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():557-63. PubMed ID: 7841089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
